| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Revenue | $2.7B | $3.0B | $3.1B | $3.0B | $2.7B |
| Cost of Revenue | $2.2B | $2.3B | $2.3B | $2.1B | $1.7B |
| Gross Profit | $0.5B | $0.6B | $0.9B | $0.9B | $1.0B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.7B | $0.8B | $0.9B | $0.9B | $1.0B |
| Operating Income | $-0.9B | $-0.9B | $-0.7B | $-0.0B | $0.0B |
| Net Income | $-0.9B | $-0.8B | $-0.8B | $-0.2B | $-0.2B |
| EPS (Basic) | $-3.82 | $-3.89 | $-3.81 | $-1.05 | — |
| EPS (Diluted) | $-3.82 | $-3.89 | $-3.81 | $-1.05 | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Total Assets | $3.1B | $4.1B | $5.5B | $6.3B | $6.4B |
| Current Assets | $0.6B | $0.7B | $1.1B | $1.0B | $0.8B |
| Cash & Equivalents | $0.1B | $0.2B | $0.2B | $0.3B | $0.1B |
| Total Liabilities | $4.1B | $4.3B | $4.8B | $5.0B | $5.0B |
| Current Liabilities | $0.8B | $0.8B | $0.9B | $0.8B | $0.7B |
| Stockholders' Equity | $-1.0B | $-0.2B | $0.6B | $1.3B | $1.4B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.4B | $0.2B | $0.4B | $0.1B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.0B | $-0.3B | $-0.2B | $-0.1B | $0.0B |